BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 11339297)

  • 1. Expedient liquid chromatographic method with fluorescence detection for montelukast sodium in micro-samples of plasma.
    Al-Rawithi S; Al-Gazlan S; Al-Ahmadi W; Alshowaier IA; Yusuf A; Raines DA
    J Chromatogr B Biomed Sci Appl; 2001 Apr; 754(2):527-31. PubMed ID: 11339297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A simple bioanalytical assay for determination of montelukast in human plasma: application to a pharmacokinetic study.
    Sripalakit P; Kongthong B; Saraphanchotiwitthaya A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jun; 869(1-2):38-44. PubMed ID: 18508416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of montelukast sodium in human plasma by column-switching high-performance liquid chromatography with fluorescence detection.
    Ochiai H; Uchiyama N; Takano T; Hara K; Kamei T
    J Chromatogr B Biomed Sci Appl; 1998 Aug; 713(2):409-14. PubMed ID: 9746257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An automated method for the determination of montelukast in human plasma using dual-column HPLC analysis and peak height summation of the parent compound and its photodegradation product.
    Smith GA; Rawls CM; Kunka RL
    Pharm Res; 2004 Sep; 21(9):1539-44. PubMed ID: 15497676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A semi-automated 96-well protein precipitation method for the determination of montelukast in human plasma using high performance liquid chromatography/fluorescence detection.
    Kitchen CJ; Wang AQ; Musson DG; Yang AY; Fisher AL
    J Pharm Biomed Anal; 2003 Mar; 31(4):647-54. PubMed ID: 12644191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous determination of febuxostat and montelukast in human plasma using fabric phase sorptive extraction and high performance liquid chromatography-fluorimetric detection.
    Gazioglu I; Evrim Kepekci Tekkeli S; Tartaglia A; Aslan C; Locatelli M; Kabir A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2022 Jan; 1188():123070. PubMed ID: 34920289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of montelukast (MK-0476) and its S-enantiomer in human plasma by stereoselective high-performance liquid chromatography with column-switching.
    Liu L; Cheng H; Zhao JJ; Rogers JD
    J Pharm Biomed Anal; 1997 Feb; 15(5):631-8. PubMed ID: 9127275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expedient microdetermination of itraconazole and hydroxyitraconazole in plasma by high-performance liquid chromatography with fluorescence detection.
    Al-Rawithi S; Hussein R; Al-Moshen I; Raines D
    Ther Drug Monit; 2001 Aug; 23(4):445-8. PubMed ID: 11477331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spectrofluorometric determination of montelukast in dosage forms and spiked human plasma.
    Alsarra I; Khalil NY; Sultan M; Al-Ashban R; Belal F
    Pharmazie; 2005 Nov; 60(11):823-6. PubMed ID: 16320943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous determination of montelukast as sparing therapy with some inhaled corticosteroids in plasma of asthmatic patients.
    Ahmed S; Atia NN
    J Pharm Biomed Anal; 2013 Feb; 74():250-6. PubMed ID: 23245258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High performance liquid chromatographic determination of cyclooxygenase II inhibitor rofecoxib in rat and human plasma.
    Jamali F; Sattari S
    J Pharm Pharm Sci; 2000; 3(3):312-7. PubMed ID: 11177649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a simplified, sensitive high-performance liquid chromatographic method using fluorescence detection to determine the concentration of UCN-01 in human plasma.
    Smith JA; Cortes J; Newman RA; Madden TL
    J Chromatogr B Biomed Sci Appl; 2001 Sep; 760(2):247-53. PubMed ID: 11530983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of a new reversible proton pump inhibitor, DBM-819, in human plasma and urine, and rat tissue homogenates by high-performance liquid chromatography.
    Kim EJ; Lee MH; Kim SH; Kim SO; Lee DH; Lim HL; Lee HS; Lee MG
    J Pharm Biomed Anal; 2002 Oct; 30(3):511-8. PubMed ID: 12367675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioanalysis of zosuquidar trihydrochloride (LY335979) in small volumes of human and murine plasma by ion-pairing reversed-phase high-performance liquid chromatography.
    Kemper EM; Ouwehand M; Beijnen JH; van Tellingen O
    J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Dec; 798(1):63-8. PubMed ID: 14630360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensitive LC-MS/MS-ESI method for simultaneous determination of montelukast and fexofenadine in human plasma: application to a bioequivalence study.
    Muppavarapu R; Guttikar S; Rajappan M; Kamarajan K; Mullangi R
    Biomed Chromatogr; 2014 Aug; 28(8):1048-56. PubMed ID: 24424850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of MK-0476 in human plasma by liquid chromatography.
    Amin RD; Cheng H; Rogers JD
    J Pharm Biomed Anal; 1995 Feb; 13(2):155-8. PubMed ID: 7766722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of NVP-BEZ235, a dual PI3K and mTOR inhibitor, in human and mouse plasma and in mouse tissue homogenates by reversed-phase high-performance liquid chromatography with fluorescence detection.
    Lin F; Chandrasekaran G; de Gooijer MC; Beijnen JH; van Tellingen O
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Jul; 901():9-17. PubMed ID: 22727754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-performance liquid chromatographic method for the determination of dasatinib in rabbit plasma using fluorescence detection and its application to a pharmacokinetic study.
    Kassem MG; Ezzeldin E; Korashy HM; Mostafa GA
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Nov; 939():73-9. PubMed ID: 24113234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High performance liquid chromatographic determination of Picumast and two active metabolites in plasma using on-line sample preparation.
    Besenfelder E
    Biomed Chromatogr; 1991 Jan; 5(1):32-7. PubMed ID: 1674434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of an HPLC method for the determination of urinary and plasma levels of N1-methylnicotinamide, an endogenous marker of renal cationic transport and plasma flow.
    Musfeld C; Biollaz J; BĂ©laz N; Kesselring UW; Decosterd LA
    J Pharm Biomed Anal; 2001 Jan; 24(3):391-404. PubMed ID: 11199218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.